Literature DB >> 30306603

Randomised clinical trial: reducing the intake of dietary FODMAPs of breastfeeding mothers is associated with a greater improvement of the symptoms of infantile colic than for a typical diet.

Marina Iacovou1, Simon S Craig2,3, Greg W Yelland1, Jacqueline S Barrett1, Peter R Gibson1, Jane G Muir1.   

Abstract

BACKGROUND: Therapeutic diets for infantile colic lack evidence. In breastfed infants, avoiding "windy" foods by the breastfeeding mother is common. AIM: To examine the effects of a maternal low-FODMAP (Fermentable, Oligosaccharides, Disaccharides, Monosaccharides, And Polyols) diet compared to a typical-Australian diet on infant crying-fussing durations of infants with colic in a randomised, double-blind, crossover feeding study.
METHODS: Between 2014 and 2016 exclusively breastfed infants aged ≤9 weeks meeting Wessel criteria for colic were recruited. Mothers were provided a 10-day low-FODMAP or typical-Australian diet, then alternated without washout. Infants without colic (controls) were observed prospectively and mothers remained on habitual diet. Infant crying-fussing durations were captured using a Barr Diary. Measures of maternal psychological status and samples of breast milk and infant faeces were collected.
RESULTS: Mean crying-fussing durations were 91 min/d in seven controls compared with 269 min/d in 13 colicky infants (P < 0.0001), which fell by median 32% during the low-FODMAP diet compared with 20% during the typical-Australian diet (P = 0.03), confirmed by a two-way mixed-model analyses-of-variance (ƞp 2  = 0.719; P = 0.049) with no order effect. In breast milk, lactose concentrations remained stable and other known dietary FODMAPs were not detected. Changes in infant faecal calprotectin were similar between diets and groups, and faecal pH did not change. Median maternal anxiety and stress fell with the typical-Australian diet (P < 0.01), but remained stable on the low-FODMAP diet.
CONCLUSIONS: Maternal low-FODMAP diet was associated with enhanced reduction in crying-fussing durations of infants with colic. This was not related to changes in maternal psychological status, gross changes in breast milk or infant faeces. Mechanisms require elucidation. Trial Registration Australian New Zealand Clinical Trials Registry (ANZCTR): 12616000512426 - anzctr.org.au.
© 2018 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30306603     DOI: 10.1111/apt.15007

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  5 in total

Review 1.  Pediatric Aspects of Nutrition Interventions for Disorders of Gut-Brain Interaction.

Authors:  Samuel Nurko; Marc A Benninga; Toni Solari; Bruno P Chumpitazi
Journal:  Am J Gastroenterol       Date:  2022-04-13       Impact factor: 12.045

2.  Efficacy and Safety of a Colic Relief Remedy in Infantile Colic.

Authors:  Charles Evans; Wladimir P Lorentz
Journal:  Glob Pediatr Health       Date:  2022-08-01

3.  Infant behavioral state and stool microbiome in infants receiving Lactocaseibacillus rhamnosus GG in formula: randomized controlled trial.

Authors:  Robert J Shulman; Maciej Chichlowski; Fabiola Gutierrez Orozco; Cheryl L Harris; Jennifer L Wampler; Nicholas A Bokulich; Carol Lynn Berseth
Journal:  BMC Pediatr       Date:  2022-10-07       Impact factor: 2.567

Review 4.  Nutritional Aspects of Pediatric Gastrointestinal Diseases.

Authors:  Teresa Di Chio; Christiane Sokollik; Diego G Peroni; Lara Hart; Giacomo Simonetti; Franziska Righini-Grunder; Osvaldo Borrelli
Journal:  Nutrients       Date:  2021-06-19       Impact factor: 5.717

5.  The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12® in infant colic: A randomised, double blind, placebo-controlled trial.

Authors:  Rita Nocerino; Francesca De Filippis; Gaetano Cecere; Antonio Marino; Maria Micillo; Carmen Di Scala; Carmen de Caro; Antonio Calignano; Cristina Bruno; Lorella Paparo; Anna M Iannicelli; Linda Cosenza; Ylenia Maddalena; Giusy Della Gatta; Serena Coppola; Laura Carucci; Danilo Ercolini; Roberto Berni Canani
Journal:  Aliment Pharmacol Ther       Date:  2019-12-03       Impact factor: 8.171

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.